High miR-26a and low CDC2 levels associate with decreased EZH2 expression and with favorable outcome on tamoxifen in metastatic breast cancer

By Jansen M.  

Breast Cancer Research and Treatment, Vol. 133, Iss. 3, 2012-06 ,pp. : 937-947

Springer Publishing Company

Access to resources Recommend Favorite

Genetic variants within miR-126 and miR-335 are not associated with breast cancer risk

By Yang Rongxi  

Breast Cancer Research and Treatment, Vol. 127, Iss. 2, 2011-06 ,pp. : 549-554

Springer Publishing Company

Access to resources Recommend Favorite

Clinical significance of miR-155 expression in breast cancer and effects of miR-155 ASO on cell viability and apoptosis

By                  

Oncology Reports, Vol. 27, Iss. 4, 2012-01 ,pp. : 1149-1155

Spandidos Publications

Access to resources Recommend Favorite

Higher expression of circulating miR182 as a novel biomarker for breast cancer

By                  

Oncology Letters, Vol. 6, Iss. 6, 2013-01 ,pp. : 1681-1686

Spandidos Publications

Access to resources Recommend Favorite

A germline mutation in the miR125a coding region reduces miR125a expression and is associated with human gastric cancer

By          

Molecular Medicine Reports, Vol. 10, Iss. 4, 2014-01 ,pp. : 1839-1844

Spandidos Publications

Access to resources Recommend Favorite